Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T34234 | Target Info | |||
Target Name | Vitamin D3 receptor (VDR) | ||||
Synonyms | Vitamin D(3) receptor; Nuclear vitamin D receptor; Nuclear receptor subfamily 1 group I member 1; NR1I1; 1,25-dihydroxyvitamin D3 receptor | ||||
Target Type | Successful Target | ||||
Gene Name | VDR | ||||
Biochemical Class | Nuclear hormone receptor | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | (1s,3r,5z,7e,14beta,17alpha,20s)-20-[5-(1-Hydroxy-1-Methylethyl)furan-2-Yl]-9,10-Secopregna-5,7,10-Triene-1,3-Diol | Ligand Info | |||
Canonical SMILES | CC(C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)C4=CC=C(O4)C(C)(C)O | ||||
InChI | 1S/C28H40O4/c1-17-20(15-21(29)16-24(17)30)9-8-19-7-6-14-28(5)22(10-11-23(19)28)18(2)25-12-13-26(32-25)27(3,4)31/h8-9,12-13,18,21-24,29-31H,1,6-7,10-11,14-16H2,2-5H3/b19-8+,20-9-/t18-,21+,22+,23-,24-,28+/m0/s1 | ||||
InChIKey | LQSIVELXOQAADQ-YQCVTLPCSA-N | ||||
PubChem Compound ID | 53313342 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 3OGT Design, Chemical synthesis, Functional characterization and Crystal structure of the sidechain analogue of 1,25-dihydroxyvitamin D3. | ||||||
Method | X-ray diffraction | Resolution | 1.75 Å | Mutation | No | [1] |
PDB Sequence |
SLRPKLSEEQ
128 QRIIAILLDA138 HHKTYDPTYS148 DFCQFRPPVR158 VNDGGGSVTL219 ELSQLSMLPH 229 LADLVSYSIQ239 KVIGFAKMIP249 GFRDLTSEDQ259 IVLLKSSAIE269 VIMLRSNESF 279 TMDDMSWTCG289 NQDYKYRVSD299 VTKAGHSLEL309 IEPLIKFQVG319 LKKLNLHEEE 329 HVLLMAICIV339 SPDRPGVQDA349 ALIEAIQDRL359 SNTLQTYIRC369 RHPPPGSHLL 379 YAKMIQKLAD389 LRSLNEEHSK399 QYRCLSFQPE409 CSMKLTPLVL419 EVFG |
|||||
|
TYR143
2.872
TYR147
3.902
PHE150
4.272
LEU227
3.758
LEU230
4.095
ALA231
4.958
LEU233
3.945
VAL234
3.555
SER237
2.731
ILE268
3.505
ILE271
3.709
MET272
4.366
ARG274
2.974
SER275
3.369
|
|||||
PDB ID: 3TKC Design, Synthesis, Evaluation and Structure of Vitamin D Analogues with Furan Side Chains | ||||||
Method | X-ray diffraction | Resolution | 1.75 Å | Mutation | No | [2] |
PDB Sequence |
SLRPKLSEEQ
128 QRIIAILLDA138 HHKTYDPTYS148 DFCQFRPPVR158 VNDGGGSVTL219 ELSQLSMLPH 229 LADLVSYSIQ239 KVIGFAKMIP249 GFRDLTSEDQ259 IVLLKSSAIE269 VIMLRSNESF 279 TMDDMSWTCG289 NQDYKYRVSD299 VTKAGHSLEL309 IEPLIKFQVG319 LKKLNLHEEE 329 HVLLMAICIV339 SPDRPGVQDA349 ALIEAIQDRL359 SNTLQTYIRC369 RHPPPGSHLL 379 YAKMIQKLAD389 LRSLNEEHSK399 QYRCLSFQPE409 CSMKLTPLVL419 EVFG |
|||||
|
TYR143
2.874
TYR147
3.895
PHE150
4.260
LEU227
3.747
LEU230
4.118
ALA231
4.975
LEU233
3.962
VAL234
3.550
SER237
2.735
ILE268
3.515
ILE271
3.678
MET272
4.375
ARG274
2.964
SER275
3.383
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Design, Chemical synthesis, Functional characterization and Crystal structure of the sidechain analogue of 1,25-dihydroxyvitamin D3. | ||||
REF 2 | Design, synthesis, evaluation, and structure of vitamin D analogues with furan side chains. Chemistry. 2012 Jan 9;18(2):603-12. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.